IL6 and type 2 diabetes mellitus: Finally, the positive correlation between IL-6 and IL-10 levels showed that, in T2DM, the increase of pro-inflammatory mediators may cause a compensatory increase in anti-inflammatory cytokines to control subclinical inflammation.